522 related articles for article (PubMed ID: 25364765)
41. The Emerging Roles of miR-125b in Cancers.
Wang Y; Zeng G; Jiang Y
Cancer Manag Res; 2020; 12():1079-1088. PubMed ID: 32104088
[TBL] [Abstract][Full Text] [Related]
42. Dynamic changes in circulating miRNA levels in response to antitumor therapy of lung cancer.
Ponomaryova AA; Morozkin ES; Rykova EY; Zaporozhchenko IA; Skvortsova TE; Dobrodeev АY; Zavyalov AA; Tuzikov SA; Vlassov VV; Cherdyntseva NV; Laktionov PP; Choinzonov EL
Exp Lung Res; 2016; 42(2):95-102. PubMed ID: 26986825
[TBL] [Abstract][Full Text] [Related]
43. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
44. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
45. miR-378 functions as an onco-miRNA by targeting the ST7L/Wnt/β-catenin pathway in cervical cancer.
Li S; Yang F; Wang M; Cao W; Yang Z
Int J Mol Med; 2017 Oct; 40(4):1047-1056. PubMed ID: 28902356
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
47. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3.
Huang L; Luo J; Cai Q; Pan Q; Zeng H; Guo Z; Dong W; Huang J; Lin T
Int J Cancer; 2011 Apr; 128(8):1758-69. PubMed ID: 20549700
[TBL] [Abstract][Full Text] [Related]
48. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
49. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
50. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
Wu M; Tan X; Liu P; Yang Y; Huang Y; Liu X; Meng X; Yu B; Wu Y; Jin H
Life Sci; 2020 Aug; 255():117857. PubMed ID: 32470446
[TBL] [Abstract][Full Text] [Related]
51. Relationship between expression of onco-related miRNAs and the endoscopic appearance of colorectal tumors.
Nakagawa Y; Akao Y; Taniguchi K; Kamatani A; Tahara T; Kamano T; Nakano N; Komura N; Ikuno H; Ohmori T; Jodai Y; Miyata M; Nagasaka M; Shibata T; Ohmiya N; Hirata I
Int J Mol Sci; 2015 Jan; 16(1):1526-43. PubMed ID: 25584614
[TBL] [Abstract][Full Text] [Related]
52. Relative levels of let-7a, miR-17, miR-27b, miR-125a, miR-125b and miR-206 as potential molecular markers to evaluate grade, receptor status and molecular type in breast cancer.
Lehmann TP; Korski K; Gryczka R; Ibbs M; Thieleman A; Grodecka-Gazdecka S; Jagodziński PP
Mol Med Rep; 2015 Sep; 12(3):4692-4702. PubMed ID: 26130254
[TBL] [Abstract][Full Text] [Related]
53. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
[TBL] [Abstract][Full Text] [Related]
54. A role for low-abundance miRNAs in colon cancer: the miR-206/Krüppel-like factor 4 (KLF4) axis.
Parasramka MA; Dashwood WM; Wang R; Saeed HH; Williams DE; Ho E; Dashwood RH
Clin Epigenetics; 2012 Sep; 4(1):16. PubMed ID: 23006636
[TBL] [Abstract][Full Text] [Related]
55. MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer.
Zhao X; He W; Li J; Huang S; Wan X; Luo H; Wu D
Am J Transl Res; 2015; 7(11):2346-54. PubMed ID: 26807182
[TBL] [Abstract][Full Text] [Related]
56. Long Non-coding RNA LINC01787 Drives Breast Cancer Progression via Disrupting miR-125b Generation.
Li Y; Song Y; Wang Z; Zhang Z; Lu M; Wang Y
Front Oncol; 2019; 9():1140. PubMed ID: 31750242
[TBL] [Abstract][Full Text] [Related]
57. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
[TBL] [Abstract][Full Text] [Related]
58. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.
Ozek NS; Tuna S; Erson-Bensan AE; Severcan F
Analyst; 2010 Dec; 135(12):3094-102. PubMed ID: 20978686
[TBL] [Abstract][Full Text] [Related]
59. Intestinal and Circulating MicroRNAs in Coeliac Disease.
Felli C; Baldassarre A; Masotti A
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28878141
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
